SK Life Science, Inc. (USA) holds 0 active US FDA Type II Drug Master Files and 1 inactive. 3 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “SK Life Science, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sk-life-science-inc

Overview

SK Life Science, Inc. is a subsidiary of SK Biopharmaceuticals, focused on developing therapies for neurological disorders. The company is committed to bringing innovative treatments to patients with unmet medical needs.

Therapeutic areas

API / Drug Master Files

SK Life Science, Inc. holds 0 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • CARISBAMAT (RWJ 333369)Inactive2008-10-22

FDA compliance signals

3 FDA enforcement records linked to this company.

  • 4832021-08-11

    Failure to report non-alert ADEs

  • 4832021-08-11

    Failure to develop written procedures

  • 4832021-08-11

    Late submission of 15-day report

For suppliers

Is this SK Life Science, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.